Comment

Amgen's Otezla Wins FDA Approval For Psoriasis, Regardless Of Severity Level

The FDA has approved Amgen Inc's Otezla (apremilast) to treat adult patients with plaque psoriasis w
Amgen's Otezla Wins FDA Approval For Psoriasis, Regardless Of Severity Level

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

举报

评论

  • 推荐
  • 最新
empty
暂无评论